BRUKER CORP
BRKRAPI behind this page
BRKR Q1 2026 request
Playground key active
/api/financials?ticker=BRKR&year=2026&quarter=1
Pick an endpoint and run the request.
Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 823.4 | 801.4 | +2.7% |
Show Product Lines breakouts |
|||
| Product | 646.4 | 643.3 | +0.5% |
| Product And Service Other | 177 | 158.1 | +12.0% |
Show Business Segments breakouts |
|||
| BEST | 63.6 | 56.9 | +11.8% |
| BEST · Intersegment Elimination | 3.2 | 2.4 | +33.3% |
| BEST · Operating Segments | 66.8 | 59.3 | +12.6% |
| BSI BioSpin | 197.5 | 207.8 | -5.0% |
| BSI BioSpin · Operating Segments | 197.5 | 207.8 | -5.0% |
| BSI CALID | 316.3 | 280.1 | +12.9% |
| BSI CALID · Operating Segments | 316.3 | 280.1 | +12.9% |
| BSI NANO | 246 | 256.6 | -4.1% |
| BSI NANO · Operating Segments | 246 | 256.6 | -4.1% |
Show Geography breakouts |
|||
| Asia Pacific Excluding China | 134.7 | 131.4 | +2.5% |
| CN | 74 | 101.2 | -26.9% |
| DE | 62.7 | 61.1 | +2.6% |
| Europe Excluding Germany | 258.9 | 224.1 | +15.5% |
| Other | 71.2 | 66.2 | +7.6% |
| US | 221.9 | 217.4 | +2.1% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | 3.2 | 2.4 | +33.3% |
| Operating Segments | 826.6 | 803.8 | +2.8% |
Show Business Acquisition breakouts |
|||
| 2026 Acquisitions | 13 | — | — |
Show Timing Of Transfer Of Good Or Service breakouts |
|||
| Transferred At Point In Time | 688.3 | 678.7 | +1.4% |
| Transferred Over Time | 135.1 | 122.7 | +10.1% |
| Cost of Revenue | 443.6 | 410.2 | +8.1% |
Show Product Lines breakouts |
|||
| Product | 347.6 | 322.3 | +7.8% |
| Product And Service Other | 96 | 87.9 | +9.2% |
| Gross Profit | 379.8 | 391.2 | -2.9% |
| Selling, General & Administrative | 242.1 | 225.4 | +7.4% |
Show Business Segments breakouts |
|||
| BEST · Operating Segments | 5.9 | 5.3 | +11.3% |
| BSI BioSpin · Operating Segments | 41.8 | 39 | +7.2% |
| BSI CALID · Operating Segments | 81.3 | 72.9 | +11.5% |
| BSI NANO · Operating Segments | 68.5 | 69.3 | -1.2% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 197.5 | 186.5 | +5.9% |
| Research & Development | 101.3 | 97.1 | +4.3% |
Show Business Segments breakouts |
|||
| BEST · Operating Segments | 0.8 | 0.6 | +33.3% |
| BSI BioSpin · Operating Segments | 24.2 | 22 | +10.0% |
| BSI CALID · Operating Segments | 33.1 | 27.9 | +18.6% |
| BSI NANO · Operating Segments | 42.9 | 45.3 | -5.3% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 101 | 95.8 | +5.4% |
| Other Nonrecurring Expense | 26.2 | 36.9 | -29.0% |
| Operating Expenses | 369.6 | 359.4 | +2.8% |
| Operating Income | 10.2 | 31.8 | -67.9% |
Show Business Segments breakouts |
|||
| Adjustments and Reconciling Items | 74.1 | 70 | +5.9% |
| BEST · Operating Segments | 7.6 | 7 | +8.6% |
| BSI BioSpin · Operating Segments | 28.8 | 37.1 | -22.4% |
| BSI CALID · Operating Segments | 62.6 | 61.5 | +1.8% |
| BSI NANO · Operating Segments | 14.4 | 23.1 | -37.7% |
Show Consolidation Items breakouts |
|||
| Corporate, eliminations and other | 29.1 | 26.9 | +8.2% |
| Operating Segments | 113.4 | 128.7 | -11.9% |
| Other Non-Operating Income (Expense) | 11.7 | -6.7 | +274.6% |
| Income Before Taxes | 21.9 | 25.1 | -12.7% |
Show Business Acquisition breakouts |
|||
| 2026 Acquisitions | 0.5 | — | — |
| Income Tax Expense (Benefit) | 2.5 | 8.7 | -71.3% |
| Equity In Income Losses Of Unconsolidated Investees Net Of Tax | -3.7 | 0.4 | -1025.0% |
| Net Income | 15.7 | 16.8 | -6.5% |
| Net Income Loss Attributable To Noncontrolling Interest | 1.3 | -0.6 | +316.7% |
| Net Income | 14.4 | 17.4 | -17.2% |
| Preferred Stock Dividends And Other Adjustments | 10.9 | — | — |
| Net Income Loss Available To Common Stockholders Basic | 3.5 | 17.4 | -79.9% |
| EPS (Basic) | 0.02 | 0.11 | -81.8% |
| EPS (Diluted) | 0.02 | 0.11 | -81.8% |
| Wtd Avg Shares (Basic) | 152.2 | 151.6 | +0.4% |
| Wtd Avg Shares (Diluted) | 152.7 | 151.9 | +0.5% |
| Non-Operating Income (Expense) | 11.7 | -6.7 | +274.6% |
| Interest Expense | -12.2 | -13.1 | +6.9% |
| Interest Income | 4.9 | 3.1 | +58.1% |
| Comprehensive Income | 3.7 | 47.9 | -92.3% |
| Other Comprehensive Income | -11.5 | 31.6 | -136.4% |
| Foreign Currency Transaction Gain Loss Before Tax | 4.4 | 4.3 | +2.3% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 133.4 | 184.2 | -27.6% |
| Accounts Receivable | 542.7 | 537.8 | +0.9% |
| Inventory | 1,121.5 | 1,116.5 | +0.4% |
| Other Assets Current | 306 | 273 | +12.1% |
| Total Current Assets | 2,103.6 | 2,111.5 | -0.4% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 719.6 | 689 | +4.4% |
| Other Non-Current Assets | 832.2 | 698 | +19.2% |
| Total Assets | 6,130.7 | 5,933.1 | +3.3% |
Show Business Segments breakouts |
|||
| BEST · Operating Segments | 194.7 | 204.9 | -5.0% |
| BSI Biospin, BSI CALID, BSI NANO & Corporate · Operating Segments | 5,978.4 | 5,768.6 | +3.6% |
Show Consolidation Items breakouts |
|||
| Corporate, eliminations and other | -42.4 | -40.4 | -5.0% |
| Goodwill | 1,572.9 | 1,532.9 | +2.6% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 36.4 | — | — |
Show Business Acquisition breakouts |
|||
| Tofwerk | 36.4 | — | — |
| Intangible Assets | 902.4 | 901.7 | +0.1% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Customer Relationships | 415.3 | 420.8 | -1.3% |
| Other Intangible Assets | 2.1 | 8.2 | -74.4% |
| Technology Based Intangible Assets | 445.1 | 428.8 | +3.8% |
| Trade Names | 39.9 | 43.9 | -9.1% |
| Other Assets | |||
| Intangible Assets Net Including Goodwill | 2,475.3 | 2,434.6 | +1.7% |
| Current Liabilities | |||
| Long Term Debt And Capital Lease Obligations Current | 8.4 | 37.7 | -77.7% |
| Accounts Payable | 269.1 | 244.6 | +10.0% |
| Deferred Revenue (Current) | 479.7 | 470.6 | +1.9% |
| Other Liabilities Current | 597.9 | 592 | +1.0% |
| Total Current Liabilities | 1,355.1 | 1,344.9 | +0.8% |
| Non-Current Liabilities | |||
| Long-Term Debt | 1,662.9 | 2,076.1 | -19.9% |
| Other Non-Current Liabilities | 609.9 | 660.9 | -7.7% |
| Long-Term Debt | 1,671.3 | 2,113.8 | -20.9% |
Show Debt Instrument breakouts |
|||
| Finance lease obligations | 18.4 | 18.1 | +1.7% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 35.8 | 18.3 | +95.6% |
| Stockholders' Equity | |||
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2,467 | 1,832.9 | +34.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -90.2 | -73.1 | -23.4% |
| Additional Paid In Capital | 1,421.6 | 719.3 | +97.6% |
| Common Stock | 1.8 | 1.8 | 0.0% |
| Noncontrolling Interest | 17.9 | 15.7 | +14.0% |
| Parent | 2,449.1 | 1,817.2 | +34.8% |
| Redeemable Noncontrolling Interests | 35.8 | 18.3 | +95.6% |
| Retained Earnings | 2,358.1 | 2,416.4 | -2.4% |
| Treasury Stock Common | -1,242.2 | -1,247.2 | +0.4% |
| Total Liabilities & Equity | 6,130.7 | 5,933.1 | +3.3% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 58.3 | 50.4 | +15.7% |
Show Business Segments breakouts |
|||
| BEST | 2.6 | 2.1 | +23.8% |
| BSI BioSpin | 11.7 | 10.4 | +12.5% |
| BSI CALID | 24.6 | 19.8 | +24.2% |
| BSI NANO | 17 | 16.7 | +1.8% |
| Corporate | 2.4 | 1.4 | +71.4% |
| Other Non-Cash Items | 21.4 | -11.5 | +286.1% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | 11.2 | 26.4 | -57.6% |
| Change in Inventory | -47.2 | -28.4 | -66.2% |
| Increase Decrease In Other Operating Capital Net | 11.8 | 11.3 | +4.4% |
| Net Cash from Operations | 71.2 | 65 | +9.5% |
| Investing Activities | |||
| Capital Expenditures | -24.2 | -26 | +6.9% |
| Payments To Acquire Businesses Net Of Cash Acquired | -16 | -1.1 | -1354.5% |
| Other Investing Activities | 0.5 | 1 | -50.0% |
| Net Cash from Investing | -39.7 | -26.1 | -52.1% |
| Financing Activities | |||
| Repayments Of Long Term Debt | -181.3 | -7.7 | -2254.5% |
Show Long-Term Debt Type breakouts |
|||
| CHF Notes Under the 2024 Term Loan Agreement | -179.1 | -2.1 | -8428.6% |
| Payments Of Dividends Preferred Stock And Preference Stock | -11 | — | — |
| Payments Of Dividends Common Stock | -7.6 | -7.7 | +1.3% |
| Proceeds From Payments For Other Financing Activities | -5 | -0.7 | -614.3% |
| Net Cash from Financing | -204.9 | -51.2 | -300.2% |
| Supplemental | |||
| Interest Paid | 10.9 | 12.5 | -12.8% |
| Income Taxes Paid | 24.3 | 66.4 | -63.4% |
| Restricted Cash And Cash Equivalents | 4.2 | 3.5 | +20.0% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 7.9 | 13.3 | -40.6% |
| Net Change in Cash | -165.5 | 1 | -16650.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 137.6 | 187.7 | -26.7% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.